Sign In
Buy MRVI
$6.07
-0.160 (-2.57%)
At Close: Aug 10, 2026
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down – Here’s Why
04:12am, Sunday, 09'th Aug 2026
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) shares gapped down before the market opened on Friday. The stock had previously closed at $6.25, but opened at $5.60. Maravai LifeS
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript
06:24am, Friday, 07'th Aug 2026
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript
Maravai LifeSciences Q2 Earnings Call Highlights
01:06am, Friday, 07'th Aug 2026
Maravai LifeSciences (NASDAQ: MRVI) reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its adjus
Maravai LifeSciences Q2 Earnings Call Highlights
01:05am, Friday, 07'th Aug 2026
Maravai LifeSciences NASDAQ: MRVI reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its adjuste
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates
06:40pm, Thursday, 06'th Aug 2026
Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.08 per share a year a
Maravai LifeSciences Reports Second Quarter 2026 Financial Results
04:01pm, Thursday, 06'th Aug 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
04:02pm, Wednesday, 22'nd Jul 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its se
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new pa
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
09:02am, Tuesday, 16'th Jun 2026
TriLink, part of Maravai LifeSciences (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to h
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
08:30am, Tuesday, 16'th Jun 2026
JUPITER, Fla.--(BUSINESS WIRE)--TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA t
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
08:30am, Wednesday, 03'rd Jun 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that cert
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
04:00pm, Monday, 18'th May 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company w
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable
10:19am, Monday, 18'th May 2026
Maravai LifeSciences Holdings, Inc. is upgraded to Buy, driven by operational restructuring, improved guidance, and sector recovery. MRVI raised 2026 revenue guidance to $205–$215M and adjusted EBIT
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
11:57am, Sunday, 10'th May 2026
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
Maravai LifeSciences Q1 Earnings Call Highlights
04:10pm, Friday, 08'th May 2026
Maravai LifeSciences NASDAQ: MRVI reported first-quarter fiscal 2026 results that management said marked a “strong start to 2026,” driven by growth at its TriLink segment, steady contribution from
